142355-80-4 Usage
Description
1-Boc-4-(4-Methoxy-4-oxo-2-butenyl)piperidine is a chemical compound characterized by the molecular formula C16H27NO3. It is a derivative of piperidine, featuring a tert-butoxycarbonyl (Boc) protecting group on the nitrogen atom and a 4-(4-methoxy-4-oxo-2-butenyl) substituent on the piperidine ring. 1-Boc-4-(4-Methoxy-4-oxo-2-butenyl)piperidine is recognized for its versatility in organic synthesis and its potential applications in the pharmaceutical industry.
Uses
Used in Organic Synthesis:
1-Boc-4-(4-Methoxy-4-oxo-2-butenyl)piperidine is used as a building block in organic synthesis for the preparation of various pharmaceuticals and organic compounds. Its ability to undergo a range of chemical transformations makes it a valuable reagent in the field of organic chemistry.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1-Boc-4-(4-Methoxy-4-oxo-2-butenyl)piperidine is utilized as a key intermediate in the synthesis of drugs. Its unique structure and reactivity contribute to the development of new therapeutic agents with potential medicinal properties.
It is important to handle 1-Boc-4-(4-Methoxy-4-oxo-2-butenyl)piperidine with care due to its potential health hazards upon exposure. Proper safety measures should be taken to minimize risks associated with its use in research and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 142355-80-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,3,5 and 5 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 142355-80:
(8*1)+(7*4)+(6*2)+(5*3)+(4*5)+(3*5)+(2*8)+(1*0)=114
114 % 10 = 4
So 142355-80-4 is a valid CAS Registry Number.
InChI:InChI=1/C15H25NO4/c1-15(2,3)20-14(18)16-10-8-12(9-11-16)6-5-7-13(17)19-4/h5,7,12H,6,8-11H2,1-4H3/b7-5+
142355-80-4Relevant articles and documents
PIPERIDINYL COMPOUNDS THAT SELECTIVELY BIND INTEGRINS
-
Page 113, (2010/11/30)
The invention is directed to piperidinyl compounds of formula (I) and (II) that selectively bind integrin receptors and methods for treating an integrin mediated disorder, wherein W, R2, Z and q are described in the application.